Home
    • Plans Blog Contact
    West Pharmaceutical Services Inc logo

    West Pharmaceutical Services Inc

    WST
    Last price US$331.85
    Market cap US$25.1b
    12M price change 18.63%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Hologic IncHOLX Industry peer HaemoneticsHAE Industry peer ResMed IncRMD Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    West Pharmaceutical Services Inc Overview

    Industry: Medical Instruments & Supplies

    Sector: Healthcare

    West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania. West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Produc Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for West Pharmaceutical Services Inc into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Jul 23, 2026

    Quarterly result summary

    Net sales was $872.3M (reported); EPS was $2.37 (+28.8% YoY).

    Net sales $872.3M reported
    EPS $2.37 +28.8% YoY
    Net income/share $2.17 reported
    Net income $154M +18% YoY

    What changed

    • Net sales reported to $872.3M; EPS +28.8% YoY to $2.37.
    • Net income +18% YoY to $154M.
    • Net sales of $872.3 million increased 13.8%; organic growth was 12.7%.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q Jul 23, 2026 SEC filing 8-K Jul 23, 2026 Earnings material Earnings release Jul 23, 2026 SEC filing 10-Q Apr 23, 2026 SEC filing 8-K Apr 23, 2026 Earnings release Earnings release Apr 23, 2026 Earnings material Earnings release Apr 23, 2026 SEC filing 10-K Feb 17, 2026 Earnings release Earnings release Feb 12, 2026 SEC filing 8-K Feb 12, 2026 Earnings material Earnings release Feb 12, 2026

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 3.00/5
    West Pharmaceutical Services Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Medical Instruments & Supplies industry , Hologic Inc , Haemonetics , ResMed Inc are companies with high ratings.

    Return on Equity

    Score 4.54/5
    West Pharmaceutical Services Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    West Pharmac... WST US$25.1b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 4.85/5
    West Pharmaceutical Services Inc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    West Pharmac... WST US$25.1b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Medical Instruments & Supplies industry , Hologic Inc , Haemonetics , ResMed Inc are companies with high ratings.

    Leverage

    Score 2.85/5
    West Pharmaceutical Services Inc attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    West Pharmac... WST US$25.1b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    West Pharmaceutical Services Inc logo

    West Pharmaceutical Services Inc

    US$331.85

    US$117.00

    -64.7% vs price

    US$25.1b

    -7.93%

    18.63%